FDAFDA · Food and drugs·Recall number D-0159-2023
Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratories Ltd., India; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054
Published January 25, 2023 · Recall initiated: December 28, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Brand
- RASAGILINE
- Manufacturer
- Ascend Laboratories, LLC
- Distributor
- Customers in 19 states: CA, FL, GA, IL, KY, LA, MI, MN, MS, NC, NJ, NY, OH, PA, RI, TN, TX, WA, WI; Puerto Rico
- UPC
- 0367877260303
- Lot
- Lot # 22140903. Exp. Dec. 2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.